GW Pharmaceuticals to Present at the Cowen and Company 34th

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
GW Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference

LONDON, Feb. 26, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (AIM:GWP) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that Justin Gover, GW's Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on Monday, 3 March, 2014 at 3:30 p.m. ET. The conference will be held at the Boston Marriott Copley Place.

A live audio webcast of the presentation will be available through GW's corporate website in the investor relations section from the investor's calendar of events page at www.gwpharm.com . A replay will be available soon after the live presentation.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world's first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis in 25 countries. Sativex is also in Phase 3 clinical development as a potential treatment of pain in people with advanced cancer. This Phase 3 program is intended to support the submission of a New Drug Application for Sativex in cancer pain with the U.S. Food and Drug Administration and in other markets around the world. GW has a deep pipeline of additional cannabinoid product candidates, including Epidiolex which has received Orphan Drug Designation from the FDA for the treatment of Dravet and Lennox-Gastaut syndromes, severe, drug-resistant epilepsy syndromes. GW's product pipeline also includes compounds in Phase 1 and 2 clinical development for glioma, ulcerative colitis, type‑2 diabetes, and schizophrenia. For further information, please visit www.gwpharm.com .

Enquiries:

GW Pharmaceuticals plc (Today) + 44 20 7831 3113
Justin Gover, Chief Executive Officer (Thereafter) + 44 1980 557000
Stephen Schultz, VP Investor Relations (US) + 1 401 500 6570
   
FTI Consulting (Media Enquiries)  
Ben Atwell / Simon Conway / John Dineen (UK) + 44 20 7831 3113
Robert Stanislaro (US) +1 212 850 5657
   
Trout Group, LLC (US investor relations)  
Todd James / Chad Rubin +1 646 378 2900
   
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HanchorBio's Trispecific Strategy Boosts HCB303's Prospects

Updated Category News Views 83

Rethinking the Anti-TIGIT Game with HCB303 There's a fresh breeze blowing in the realm of immunotherapy, and it comes courtesy of HanchorBio's innovative trispecific approach. Now, for those of us who've been unimpressed by the underwhelming returns from anti-TIGIT trials, this new development might just stir the pot. HanchorBio's got the green light not only from the...

Continue Reading
SMTC: Thriving with Innovation in EMS Landscape

Updated Category News Views 65

Trailblazing in the Evolving EMS Arena SMTC's latest accolade from Frost & Sullivan isn't just another feather in their cap. It's a testament to how this mid-tier electronics manufacturing services (EMS) player stands head and shoulders above the rest. While other companies are fumbling with supply chain headaches and shifting market demands, these folks are buckling down...

Continue Reading
Southern Company Reshuffles Leadership Amidst Growth Surge

Updated Category News Views 86

Shuffling the Deck: Leadership Overhaul at Southern Company Change is in the air, folks. Southern Company isn’t just polishing the silver—it’s reshaping the whole damn table. Chris Womack’s announcement about executive leadership changes marks another chapter in Southern Company's evolution as it seeks to ramp up infrastructure investments and meet the soaring...

Continue Reading
Mondel?z Bites into Undercover: Snack Market Impact

Updated Category News Views 85

Snack World Shake-Up: Mondel?z Steps In Ever find yourself browsing the snack aisle, wondering how many brands are duking it out for shelf space? Well, brace yourself, because Mondel?z International — the big cheese in the global snack game — is grabbing a sizeable bite of Undercover Snacks. This is no small news in the land of chocolate-covered and frosted quinoa...

Continue Reading
Runners Hit NYC Streets to Spotlight Liver Disease

Updated Category News Views 46

From the Heart: Marathon Runners Champion Liver Disease Awareness There’s something raw and powerful about a community uniting to raise awareness for a cause that's touched so many lives. This Sunday, the TCS New York City Marathon becomes more than a race—it transforms into a moving tapestry of human stories, as runners take to the streets to spotlight liver disease...

Continue Reading
Orbis International to Boost Global Eye Health Efforts

Updated Category News Views 100

Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...

Continue Reading
MongoDB Faces Continued Legal Scrutiny Amid Growth Issues

Updated Category News Views 51

MongoDB's Legal Marmite: Sticky and Spreading Well, here we are, rolling up our sleeves with MongoDB, Inc. (NasdaqGM: MDB) in the spotlight again, not for some glorious tech breakthrough but a legal brouhaha. The whip of the market is as familiar as an old leather boot to traders like us. This time, we've got Kahn Swick & Foti, LLC (KSF), spearheaded by former Attorney...

Continue Reading
Ensign Lawsuit Deadline Looms: Investors, Wake Up!

Updated Category News Views 27

A Storm Brewing in Healthcare Here's what will make any half-savvy investor's pulse quicken: The Ensign Group, Inc. (NasdaqGS: ENSG) is in hot legal water, and there's a hefty class action floating around with some serious allegations. ClaimsFiler's got the word out, marking December 7, 2026, as the cut-off date for investors wanting to be part of this securities class...

Continue Reading
Avoiding Retirement Pitfalls: Smart Moves for AZ Entrepreneurs

Updated Category News Views 75

Rethinking Retirement Strategy: Navigating Common Pitfalls If you think your business sale will automatically bankroll your retirement, think again. Scott Preston from Kingman sees this as a ticking time bomb that local entrepreneurs need to defuse. The market’s fickle nature means that a once-hyped business’s value can take a nosedive if you bank too much on selling...

Continue Reading
FuelCell's Legal Storm Over Misleading Disclosures

Updated Category News Views 52

The Hard Sell on FuelCell's Promises FuelCell Energy, folks. If you've been anywhere near the market scene, you know their tale: promising clean energy with a side of misery for investors. Right now, the company finds itself in hot water over some murky disclosures about its business prowess—or lack thereof. A class action suit is brewing, and anyone with money tied up...

Continue Reading

Top 5 Most Recently Viewed Articles

The Remarkable Growth of Cboe Global Markets Over a Decade

Updated Category News Views 103

Understanding Cboe Global Markets Growth Cboe Global Markets (CBOE) has shown remarkable performance in the stock market. Over the past decade, it has consistently outpaced traditional market returns by 2.25% annually, achieving an impressive average annual return of 13.9%. This growth has culminated in a market capitalization of $21.62 billion, solidifying its status as...

Continue Reading
Integrated Analytical Solutions Opens New Cannabis Lab Facility

Updated Category News Views 160

Integrated Analytical Solutions Launches a New Cannabis Testing Facility Integrated Analytical Solutions (IAS), renowned for its analytical testing services, is making strides in the cannabis industry with the grand opening of its state-of-the-art cannabis testing laboratory. This facility is a significant addition to services aimed at promoting safety, quality, and...

Continue Reading
PagBank's Impressive 2Q25 Results Highlight Strong Growth

Updated Category News Views 155

PagBank's Stellar Financial Performance in 2Q25 PagBank, a prominent name in digital banking, has showcased impressive financial results for the second quarter of 2025, boasting a net revenue of R$5.1 billion. This reflects an 18% growth compared to previous periods, providing a solid foundation for the company’s ongoing success. The robust increase can be attributed...

Continue Reading
Analyzing the Current Strength of the S&P 500 Index

Updated Category News Views 272

The S&P 500: Continued Momentum Amid Market Uncertainties The S&P 500 index has shown impressive resilience, climbing steadily thanks to a combination of favorable economic factors, including optimism around artificial intelligence and delayed tariffs. But how sustainable is this upward trend? Buyers currently dominate the market, yet even they acknowledge that this calm...

Continue Reading
Insights on AI in Hiring: Candidate Perspectives and Trends

Updated Category News Views 137

Understanding AI's Impact on the Hiring Process In today’s competitive job market, the integration of AI in hiring is becoming increasingly significant. Companies are leveraging advanced technologies to streamline their recruitment processes, reshaping the way talent is acquired. One of the leading organizations guiding this change is Employ Inc., which focuses on...

Continue Reading